J Korean Orthop Res Soc.  2006 Oct;9(2):124-134.

Nineteen Types of WNT Genes Mediate The Differentiation of C3H10T1/2 Cell Lines

Affiliations
  • 1Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea. jkpark@catholic.ac.kr

Abstract

PURPOSE
In humans, nineteen types of WNT genes (WNTs) have been hightlighted up to date. The canonical Wnt cascade has recently emerged as a critical regulator of stem cells. To obtain new insights how nineteen WNTs affect mesenchymal stem cells differentiation, we analyzed the transcriptional activity, osteogenic and adipogenic activity of WNTs in mesenchymal stem cells.
MATERIALS AND METHODS
Recombinant adenoviruses expressing nineteen WNTs were constructed to infect pluripotent mesenchymal progenitor C3H10T1/2 cells. Transcriptional activity was determined by using the luciferase reporter assay. Osteogenic activity was determined by measuring the induction of alkaline phosphatase upon Wnt stimulation. Adipogenic activity was measured by histochemical Oil red-O staining.
RESULTS
WNT1, 2, 3, 3A and 10B significantly induced transcriptional activity in C3H10T1/2 cells. WNT1, 2, 3, 3A and 10B significantly induced alkaline phosphatase activity, but inhibited adipogenic activity in C3H10T1/2 cells. The results of qualitative and quantitative assay of alkaline phosphatase activity were consistent with those of luciferase assay for transcriptional activity and Oil red-O staining for adipogenic activity.
CONCLUSION
We could expect that WNT1, 2, 3, 3A and 10B may play a crucial role in inducing osteoblast differentiation of mesenchymal stem cells.

Keyword

WNT genes; Mesenchymal stem cells; Osteogenic activity; Osteblast differentiation

MeSH Terms

Adenoviridae
Alkaline Phosphatase
Cell Line*
Humans
Luciferases
Mesenchymal Stromal Cells
Osteoblasts
Stem Cells
Alkaline Phosphatase
Luciferases
Full Text Links
  • JKORS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr